Fact-checked by Grok 2 weeks ago

Enzyme

Enzymes are biological catalysts, primarily proteins but also including RNA molecules known as ribozymes, that accelerate the rate of chemical reactions in living organisms by lowering the activation energy required for those reactions without being consumed or permanently altered in the process.^[1]^[2]^[3] These macromolecules possess a complex three-dimensional structure, consisting of one or more polypeptide chains folded into specific shapes, with an active site—a specialized region that binds to substrate molecules to form an enzyme-substrate complex and facilitate catalysis.^[3] The binding mechanism often follows the lock-and-key model, where the active site precisely matches the substrate, or the more dynamic induced fit model, in which the enzyme adjusts its conformation upon substrate binding to optimize the reaction.^[3] Enzymes operate under physiological conditions, enabling reactions to occur at rates compatible with life, and their activity is influenced by factors such as temperature, pH, and the presence of cofactors or inhibitors.^[3]^[4] Enzymes are systematically classified by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (IUBMB) into six major classes based on the type of reaction they catalyze: oxidoreductases (EC 1, electron transfer), transferases (EC 2, group transfer), hydrolases (EC 3, hydrolysis), lyases (EC 4, addition or removal of groups to form double bonds), isomerases (EC 5, isomerization), and ligases (EC 6, bond formation coupled to ATP hydrolysis).^[5]^[6] Each enzyme is assigned a unique EC number (e.g., EC 1.1.1.1 for alcohol dehydrogenase) for precise identification, and most are named with the suffix "-ase" to indicate their catalytic function, such as amylase for starch hydrolysis.^[5]^[6] The discovery of enzymes traces back to the 19th century, with the term "enzyme" coined by Wilhelm Kühne in 1877 to describe non-cellular catalysts, building on earlier observations like Anselme Payen's isolation of diastase in 1833; the field advanced dramatically in the 1980s with the identification of ribozymes by Sidney Altman and Thomas Cech, earning them the 1989 Nobel Prize in Chemistry.^[7]^[8] In biological systems, enzymes are indispensable, with thousands present in cells to regulate metabolism, DNA replication, signal transduction, and other processes essential for sustaining life.^[3] Their specificity and efficiency underpin biotechnology applications, from industrial production to medical diagnostics, highlighting their profound impact across disciplines.^[9]

Etymology and History

Etymology

The term "enzyme" originates from the Greek phrase en zymē, meaning "in yeast" or "in leaven," and was coined in 1877 by German physiologist Wilhelm Kühne to describe the active agents responsible for fermentation processes observed in yeast.^[10] This nomenclature reflected the era's focus on yeast as a primary model for studying catalytic activity in biological systems, distinguishing these agents from the broader category of ferments.^[7] In the early 19th century, before the adoption of "enzyme," such catalytic substances were commonly termed "ferments," a concept advanced by chemists including Justus von Liebig, who interpreted fermentation as a purely chemical decomposition rather than a process tied exclusively to living organisms.^[11] Liebig and contemporaries like Jöns Jacob Berzelius used "ferment" to encompass both living and non-living agents that accelerated reactions, though debates persisted over whether these were vital forces or chemical catalysts.^[12] By the mid-19th century, ferments were often subdivided into "organized ferments," which were believed to require intact living cells (such as yeast), and "unorganized ferments," which were thought to act independently.^[12] This distinction shifted dramatically in 1897 when Eduard Buchner demonstrated that cell-free yeast extracts could still perform alcoholic fermentation, proving that the active principles—now termed enzymes—were soluble substances extractable from cells, independent of vital life processes.^[13] Buchner's discovery solidified "enzyme" as the preferred term for these non-cellular catalysts, marking a terminological evolution from organism-bound ferments to biochemical entities.^[7]

Historical Development

The recognition of enzymatic processes dates back to ancient civilizations, with the earliest known fermented beverages dating to around 7000 BCE in ancient China at the Jiahu site.^[14] Fermentation was subsequently utilized in regions such as ancient Egypt and Mesopotamia by approximately 4000 BCE for food and beverage production, unknowingly harnessing enzymatic activity in processes like brewing and bread-making. In ancient Greece, philosophers such as Aristotle documented observations of fermentation, noting in his works how substances like must (grape juice) transformed into wine through a process resembling boiling, attributing it to natural changes rather than vital forces.^[15] A pivotal advancement occurred in 1833 when French chemists Anselme Payen and Jean-François Persoz isolated diastase from germinating barley malt, marking the first preparation of an enzyme and demonstrating its ability to hydrolyze starch into sugars.^[16] This discovery laid the groundwork for enzymology as a scientific discipline, shifting focus from vague biological processes to isolable catalysts. In 1897, Eduard Buchner conducted cell-free fermentation experiments using yeast extracts, proving that enzymes could catalyze reactions without intact living cells and refuting the doctrine of vitalism; for this, he received the 1907 Nobel Prize in Chemistry.^[17] The early 20th century saw further purification and mechanistic insights, exemplified by James B. Sumner's 1926 crystallization of urease from jack bean, confirming enzymes as proteins and earning him the 1946 Nobel Prize in Chemistry (shared with John H. Northrop and Wendell M. Stanley for related work).^[18] In 1913, Leonor Michaelis and Maud Menten developed the foundational model of enzyme kinetics, describing the hyperbolic relationship between substrate concentration and reaction rate through their equation, which revolutionized quantitative studies of catalysis.^[19] Later discoveries expanded the scope of enzymology beyond proteins. In the 1980s, Thomas Cech and Sidney Altman independently demonstrated that RNA molecules could act as catalysts, termed ribozymes, challenging the protein-centric view of enzymes and earning them the 1989 Nobel Prize in Chemistry.^[20] Building on this, in the 1990s, Frances Arnold pioneered directed evolution techniques, randomly mutating enzyme genes and selecting variants for desired functions, with her first successful application in 1993; this method transformed enzyme engineering and led to her 2018 Nobel Prize in Chemistry.^[21] More recently, the 2024 Nobel Prize in Chemistry recognized advancements in protein design and structure prediction, with David Baker awarded for computational methods to create novel enzymes and Demis Hassabis and John Jumper for AI-based prediction tools like AlphaFold, which have revolutionized enzyme engineering and understanding.^[22]

Classification and Nomenclature

Enzyme Commission System

The Enzyme Commission (EC) System was established in 1956 by the International Union of Biochemistry (IUB), now known as the International Union of Biochemistry and Molecular Biology (IUBMB), to provide a standardized framework for classifying enzymes based on the reactions they catalyze and to prevent inconsistencies in nomenclature.^[23] This initiative arose from the rapid growth in enzyme discoveries during the mid-20th century, necessitating a systematic approach to organize the expanding body of knowledge.^[23] The first report of the Enzyme Commission was published in 1961, laying the foundation for the hierarchical classification that has since become the global standard.^[24] Enzymes are grouped into seven main classes under the EC System, each defined by the fundamental type of chemical transformation they facilitate. Oxidoreductases (EC 1) catalyze oxidation-reduction reactions involving electron transfer, such as dehydrogenases that manage redox processes in metabolism. Transferases (EC 2) facilitate the transfer of functional groups like amino or phosphate groups from one molecule to another. Hydrolases (EC 3) promote hydrolysis reactions, breaking bonds by adding water, as seen in proteases and lipases. Lyases (EC 4) add or eliminate groups to form double bonds without hydrolysis or oxidation, including enzymes like decarboxylases. Isomerases (EC 5) enable intramolecular rearrangements, converting a molecule into one of its isomers. Ligases (EC 6), also known as synthetases, join two molecules using energy from ATP hydrolysis. Translocases (EC 7), added in 2018, catalyze the movement of ions or molecules across membranes or their relocation within membranes.^[24]^[25] The classification employs a four-digit numerical code in the format EC a.b.c.d, reflecting a hierarchical structure that refines enzyme specificity step by step. The first digit (a) indicates the main class (1 through 7), the second (b) denotes the subclass based on the type of reaction or substrate, the third (c) specifies the sub-subclass by further reaction details or bond involvement, and the fourth (d) identifies the serial number of the specific enzyme within that group. For instance, EC 1.1.1.1 designates alcohol dehydrogenase, an oxidoreductase that acts on primary or secondary alcohols using NAD+ as an acceptor.^[24]^[26] This numbering ensures unique identification and allows for systematic expansion as new enzymes are characterized. The EC System is dynamically maintained through the ExplorEnz database, the official IUBMB repository for enzyme nomenclature and classification, which undergoes regular updates to incorporate newly discovered or reclassified enzymes. As of the 2025.11 release, the database includes over 6,900 entries, with proposed changes subjected to a four-week public review period before integration.^[27] This ongoing curation by the Nomenclature Committee of the IUBMB ensures the system's relevance and accuracy in reflecting advances in enzymology.^[28]

Nomenclature Conventions

Enzymes are assigned both trivial and systematic names to facilitate clear and unambiguous communication in scientific literature. Trivial names, also known as recommended or accepted names, are concise and descriptive terms that often reflect the enzyme's function, source, or historical discovery, such as "trypsin" for a serine protease that hydrolyzes peptide bonds in proteins.^[29] These names are preferred for general use due to their brevity and familiarity but must be linked to the specific reaction catalyzed to avoid confusion.^[24] Systematic names, in contrast, provide a more precise description of the biochemical reaction by specifying the substrates involved and the type of transformation, typically in the format "substrate:product [reaction type]" or similar. For example, the systematic name for trypsin is "protein + H₂O = protein + peptide," emphasizing its endopeptidase activity on peptide bonds.^[29] This naming convention ensures that the name directly mirrors the catalyzed reaction, using accepted trivial names for complex substrates where possible to maintain usability.^[24] The International Union of Biochemistry and Molecular Biology (IUBMB), through its Nomenclature Committee (NC-IUBMB), established these conventions in the 1978 recommendations, which have been periodically updated to incorporate new enzymatic activities and refine terminology.^[29] The guidelines mandate that enzyme names reflect the overall reaction catalyzed, based on experimental evidence of physiological substrates, and prohibit names derived solely from sequence similarity or non-enzymatic properties.^[24] Updates, such as those in the 1992 edition and subsequent supplements through 2025, address evolving knowledge while preserving the core principles.^[30] For multi-substrate reactions, nomenclature prioritizes the primary physiological substrates, listing additional ones in parentheses if they significantly contribute to the enzyme's function, to avoid overly complex names. For instance, in acetyl-CoA C-acetyltransferase (EC 2.3.3.9), the name specifies "acetyl-CoA:acetyl-CoA C-acetyltransferase" but includes qualifiers like "(thioester-hydrolysing, carboxymethyl-forming)" for clarity on mechanism.^[29] Ambiguities are resolved by creating separate entries for enzymes with distinct specificities or mechanisms, even if reactions appear similar, ensuring each name corresponds to a unique catalytic profile. Recommended names are finalized after review, while provisional or working names may be used during initial characterization.^[24] Enzyme nomenclature integrates with gene naming systems by associating EC numbers with gene symbols in databases, allowing sequence-based annotation of function; for example, the ECOD database uses structural homology to link protein domains to EC classifications, aiding in gene-enzyme correspondence.^[24]^[31] This complementary approach supports bioinformatics tools in predicting enzymatic roles from genomic data without altering the core reaction-based naming rules.^[32]

Structure

Chemical Composition

Enzymes are predominantly composed of proteins, which are linear polymers formed from 20 standard amino acids linked by peptide bonds. These amino acids include glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, serine, threonine, cysteine, methionine, asparagine, glutamine, aspartic acid, glutamic acid, lysine, arginine, histidine, and proline, each contributing unique side chains that determine the enzyme's functional properties. The primary structure of these polypeptide chains, dictated by the genetic code, serves as the foundation for higher-order organization, ultimately influencing the enzyme's catalytic efficiency. Although most enzymes are proteins, a small subset known as ribozymes are composed of RNA molecules capable of catalytic activity. Notable examples include self-splicing introns in Tetrahymena thermophila, where the RNA folds to form an active site that cleaves and rejoins phosphodiester bonds without protein assistance. Ribozymes demonstrate that RNA can mimic protein enzyme functions, supporting theories on the RNA world hypothesis in early evolution. Post-translational modifications significantly alter the chemical composition of enzymes, enhancing their stability, localization, or activity. Common modifications include glycosylation, where carbohydrate groups are covalently attached to asparagine, serine, or threonine residues, and phosphorylation, which adds phosphate groups to serine, threonine, or tyrosine side chains, often regulating enzymatic function through charge alterations. These modifications can introduce functional groups that fine-tune substrate specificity or enable interactions with cellular components. Enzyme molecular weights vary widely but typically range from 10 to 100 kDa for monomeric forms, reflecting the number of amino acids (roughly 100-900 residues). Larger enzymes, such as DNA polymerase III, can exceed 300 kDa due to multi-subunit assemblies, allowing for complex functions like DNA replication. Specific amino acids play critical roles in catalysis; for instance, in serine proteases like chymotrypsin, histidine acts as a general base to facilitate nucleophilic attack by the serine hydroxyl group. This composition directly impacts the enzyme's ability to fold into functional conformations.

Three-Dimensional Architecture

The three-dimensional architecture of enzymes, as specialized proteins, is organized hierarchically across primary, secondary, tertiary, and quaternary levels, with each level contributing to the stability and functional specificity essential for catalysis. The primary structure consists of the linear sequence of amino acids covalently linked by peptide bonds, which serves as the foundational blueprint determining all subsequent folding patterns, as established by Christian Anfinsen's thermodynamic hypothesis through experiments on ribonuclease A folding.^[33] This sequence encodes the information needed for the protein to achieve its native conformation under physiological conditions, ensuring the enzyme's structural integrity and reactivity.^[3] At the secondary structure level, segments of the polypeptide chain fold into local conformations such as α-helices, β-sheets, and unstructured loops, primarily stabilized by hydrogen bonds between backbone atoms. These elements form the building blocks of the enzyme's scaffold, providing rigidity and flexibility that facilitate substrate positioning and dynamic movements during catalysis.^[34] The tertiary structure represents the global three-dimensional arrangement of these secondary elements into a compact fold, driven by non-covalent interactions including hydrophobic effects that bury nonpolar residues in the core, electrostatic forces, van der Waals interactions, and covalent disulfide bridges in some cases. This folding creates a stable globular domain that shields reactive groups and orients functional regions precisely, enabling efficient enzymatic activity.^[35] For enzymes requiring cooperative or regulated function, a quaternary structure assembles multiple polypeptide subunits into a functional complex, often through similar intermolecular interactions as in tertiary folding. A representative example is lactate dehydrogenase, a tetrameric enzyme with four identical subunits that enhance allosteric regulation and catalytic efficiency.^[3] Common structural motifs recur across enzyme families, underscoring evolutionary conservation for functional versatility; the TIM barrel, characterized by eight alternating α-helices and β-strands forming a cylindrical core, is prevalent in metabolic enzymes like triosephosphate isomerase, providing a robust framework for diverse reactions.^[36] Similarly, the Rossmann fold, featuring parallel β-sheets flanked by α-helices, dominates in nucleotide-binding dehydrogenases such as alcohol dehydrogenase, optimizing cofactor interactions.^[37] These folds and overall architectures are systematically classified in databases like SCOP (Structural Classification of Proteins) and CATH (Class, Architecture, Topology, Homologous superfamily), which organize enzyme domains by structural similarity to reveal evolutionary relationships and design principles.^[38]^[39]

Active Site Characteristics

The active site of an enzyme is a specialized region, typically a pocket or cleft on the protein's surface, formed by the precise arrangement of specific amino acid residues that enable substrate recognition and catalysis. These residues, often distant in the primary sequence, converge in the three-dimensional structure to create a microenvironment optimized for chemical reactions, with the site's geometry dictating the enzyme's specificity and efficiency. For instance, in serine proteases like chymotrypsin, the active site features a catalytic triad composed of serine, histidine, and aspartate residues, where the nucleophilic serine hydroxyl group is positioned for attack on the substrate, facilitated by hydrogen bonding from histidine and stabilization by aspartate. Binding pockets within the active site are tailored to accommodate substrates based on their chemical properties; hydrophobic pockets, lined with non-polar amino acids such as leucine or valine, interact with non-polar substrates through van der Waals forces, while charged or polar pockets incorporate residues like arginine or glutamate to form electrostatic interactions or hydrogen bonds with polar or ionic substrates. Specificity is further determined by the active site's size, shape, and electrostatic profile, which ensure selective substrate binding and exclude non-cognate molecules—for example, the oxyanion hole in proteases, formed by backbone amide groups, stabilizes negatively charged transition states through hydrogen bonding, enhancing catalytic precision. Visualization of active site characteristics has been advanced through techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy (cryo-EM), which reveal atomic-level details of the site's architecture.^[40] A classic example is hen egg-white lysozyme, where X-ray crystallography in the 1960s disclosed a long, narrow cleft in the active site that accommodates the polysaccharide substrate, with key residues like Glu35 and Asp52 positioned for acid-base catalysis. These methods, often complemented by computational modeling, continue to elucidate how subtle variations in active site features underpin enzymatic diversity across biological systems.

Mechanism of Catalysis

Substrate Binding

Substrate binding is the initial step in enzyme catalysis, where the substrate molecule is recognized and attached to the enzyme's active site through specific interactions that ensure high selectivity. The classical model for this process, proposed by Emil Fischer in 1894, describes the enzyme and substrate as possessing complementary geometric shapes, analogous to a lock and key, allowing only the correct substrate to fit precisely into the rigid active site of the enzyme.^[41] This lock-and-key hypothesis emphasized the structural specificity that prevents non-substrate molecules from binding effectively, thereby explaining the observed selectivity of enzymatic reactions.^[42] Subsequent observations revealed limitations in the rigid lock-and-key model, leading to the induced fit model introduced by Daniel E. Koshland in 1958. In this framework, the enzyme undergoes a conformational change upon initial substrate contact, adjusting its active site to achieve a tighter, more complementary fit that not only enhances specificity but also positions catalytic residues optimally for the reaction.^[42] This dynamic adjustment is particularly evident in enzymes like hexokinase, where substrate binding induces a large-scale closure of the active site cleft, excluding water and stabilizing the transition state.^[43] The energy of substrate binding arises primarily from non-covalent interactions between the substrate and amino acid residues in the active site, including hydrogen bonds, ionic bonds, and van der Waals forces, which collectively contribute to the enzyme's specificity by discriminating against incorrect substrates.^[44] These interactions lower the free energy of the enzyme-substrate complex relative to the unbound state, with hydrogen bonds often providing directional precision and van der Waals forces enabling close-range attractions.^[45] The strength of substrate binding is quantitatively assessed by the dissociation constant K_d, defined as K_d = \frac{[E][S]}{[ES]}, where [E] is the concentration of free enzyme, [S] is the concentration of free substrate, and [ES] is the concentration of the enzyme-substrate complex at equilibrium.^[46] A lower K_d value indicates higher binding affinity, reflecting tighter interactions that are crucial for efficient catalysis in physiological conditions.^[47]

Catalytic Process

Enzymes facilitate the transformation of substrates into products by stabilizing the transition state of the reaction, thereby lowering the activation energy barrier through mechanisms such as electrostatic interactions, acid-base catalysis, and the formation of covalent intermediates.^[48] Electrostatic catalysis involves charged residues in the active site that stabilize polar transition states via hydrogen bonding or ionic interactions, while acid-base catalysis employs proton donors and acceptors, often from amino acid side chains like histidine or aspartate, to facilitate proton transfer during the reaction.^[49] Covalent catalysis occurs when a nucleophilic group on the enzyme, such as a serine residue, forms a transient covalent bond with the substrate, creating a reactive intermediate that lowers the energy of subsequent steps. In hydrolases, such as serine proteases, catalysis often proceeds via nucleophilic attack by the enzyme's serine hydroxyl group on the substrate's carbonyl carbon, forming a tetrahedral intermediate that is stabilized by the oxyanion hole in the active site.^[50] For oxidoreductases, exemplified by alcohol dehydrogenase, the mechanism involves hydride transfer from the substrate alcohol to the NAD+ coenzyme, facilitated by zinc coordination that polarizes the substrate and positions it for efficient transfer.^[51] These catalytic strategies enable enzymes to accelerate reaction rates by factors up to 10^{20}-fold compared to uncatalyzed reactions in solution.^[52] The turnover number, denoted as k_{cat}, represents the maximum number of substrate molecules converted to product per enzyme molecule per second under saturating substrate conditions, reflecting the enzyme's catalytic efficiency once the substrate is bound.^[53]

Conformational Dynamics

Enzymes exhibit intrinsic conformational dynamics that involve flexible movements such as hinge bending and loop closing, which are essential for their catalytic function. These motions allow the protein to transition between open and closed states, facilitating the accommodation of substrates and the stabilization of transition states during catalysis. For instance, in hexokinase, binding of glucose induces a large hinge-bending motion between its two domains, closing the active site cleft by approximately 8 Å to enclose the substrate and exclude water, thereby enhancing specificity and efficiency.^[54]^[55] Molecular dynamics (MD) simulations and time-resolved spectroscopy are key techniques for probing these dynamics at atomic and temporal resolutions. MD simulations model the time evolution of enzyme structures, revealing how thermal fluctuations drive hinge and loop motions on picosecond to microsecond timescales, as demonstrated in studies of adenylate kinase where hinge unfolding correlates with substrate access. Time-resolved fluorescence spectroscopy, such as single-molecule Förster resonance energy transfer (smFRET), captures real-time conformational changes, for example, in horseradish peroxidase, where active-site fluctuations occur on nanosecond scales and synchronize with catalytic turnover.^[56]^[57]^[58] These dynamics play a critical role in enabling substrate entry and exit while stabilizing the transition state to lower activation barriers. In the catalytic cycle, loop closing motions position catalytic residues optimally, reducing entropy loss and promoting efficient proton transfer or nucleophilic attack. For HIV-1 protease, conformational fluctuations in the flap regions—opening and closing on millisecond timescales—allow substrate binding and have informed inhibitor design by targeting semi-open states to trap the enzyme in non-productive conformations, improving antiviral efficacy. Such intrinsic flexibility underpins the induced fit model, where dynamics adapt the enzyme to substrates without requiring external regulators.^[59]^[60]^[61]

Cofactors and Coenzymes

Inorganic Cofactors

Inorganic cofactors, primarily divalent and transition metal ions such as Zn²⁺, Mg²⁺, Fe²⁺/Fe³⁺, and Cu²⁺, serve as essential non-organic auxiliaries in enzyme catalysis, enabling reactions without being consumed themselves. These ions are present in more than one-third of known proteins, where they coordinate with specific amino acid residues to facilitate diverse biochemical processes.^[62] Representative examples illustrate their catalytic roles. In carbonic anhydrase II, Zn²⁺ acts as a Lewis acid by coordinating a water molecule, lowering its pKa from approximately 10 to 7 and generating a nucleophilic hydroxide ion at physiological pH to hydrate CO₂ into bicarbonate.^[63] Similarly, Mg²⁺ in kinases like adenylate kinase coordinates the phosphate groups of ATP and ADP, optimizing the nucleophilic attack angle to nearly 180° and enhancing phosphoryl transfer efficiency by over 40,000-fold.^[64] In cytochromes, Fe²⁺/Fe³⁺ undergoes redox cycling within the heme group, transferring electrons in mitochondrial respiration with a standard reduction potential around +260 mV that supports efficient energy capture.^[65] The primary functions of these cofactors include Lewis acid catalysis, where redox-inert ions like Zn²⁺ polarize substrates to activate nucleophiles; redox mediation, as seen with Fe ions that alternate oxidation states to shuttle electrons; and structural stabilization, such as Zn²⁺ reinforcing protein folds in zinc-finger motifs to maintain active site integrity.^[66] Metal ions typically bind through coordinate covalent interactions with amino acid side chains, often forming tetrahedral geometries with histidine imidazole nitrogens—for example, Zn²⁺ in carbonic anhydrase is ligated by His94, His96, and His119 alongside a solvent molecule.^[63] These bindings integrate seamlessly with the apoenzyme structure to form the active holoenzyme. Disruptions in metal homeostasis can severely impair enzyme function. In Wilson's disease, mutations in the ATP7B gene cause hepatic copper accumulation, reducing activity in Cu-dependent enzymes such as ceruloplasmin (a ferroxidase), cytochrome c oxidase (essential for ATP synthesis), and superoxide dismutase (an antioxidant), leading to oxidative stress, liver damage, and neurological deficits.^[67]

Organic Coenzymes

Organic coenzymes are non-protein organic compounds, typically derived from vitamins, that serve as transient carriers of chemical groups during enzymatic reactions. Unlike prosthetic groups tightly bound to enzymes, these coenzymes loosely associate with the active site and function as second substrates, accepting or donating moieties such as hydride ions, electrons, acyl groups, or amino groups to facilitate catalysis. Their vitamin origins ensure dietary dependence, as most organisms cannot synthesize these precursors de novo.^[68] A key example is nicotinamide adenine dinucleotide (NAD⁺/NADH), biosynthesized from niacin (vitamin B₃). In dehydrogenases, NAD⁺ acts as an oxidant by accepting a hydride ion (H⁻) from the substrate at the C4 position of its nicotinamide ring, forming NADH and enabling oxidation reactions such as the conversion of lactate to pyruvate. NADH subsequently donates the hydride to other acceptors, regenerating NAD⁺ for reuse in a cyclic manner, distinct from the consumption of primary substrates.^[69] Flavin adenine dinucleotide (FAD), derived from riboflavin (vitamin B₂), participates in electron transport within flavoprotein oxidoreductases. FAD accepts two electrons and two protons to form FADH₂ through semiquinone intermediates, supporting reactions like succinate oxidation to fumarate; it is then reoxidized by downstream electron acceptors such as ubiquinone, allowing continuous cycling without net consumption.^[69] Coenzyme A (CoA), synthesized from pantothenic acid (vitamin B₅), functions as an acyl group carrier in transferase enzymes involved in metabolism. The terminal thiol (-SH) group of CoA forms high-energy thioester linkages with acyl moieties, as in acetyl-CoA during fatty acid β-oxidation or citrate synthesis; upon transfer of the acyl group to an acceptor, free CoA is released and recycled for subsequent activations.^[69] Pyridoxal 5'-phosphate (PLP), derived from pyridoxine (vitamin B₆), enables amino group transfer in transaminases and other amino acid-modifying enzymes. PLP forms a covalent Schiff base with the substrate amino acid via its aldehyde group, facilitating proton abstraction and group exchange—such as converting an amino acid to its corresponding α-keto acid—before reacting with a second substrate to regenerate the free coenzyme.^[69] These coenzymes are regenerated through coupled metabolic pathways, ensuring their availability for multiple turnover events in enzymatic catalysis.^[68]

Thermodynamics

Energy Barriers

Enzymes accelerate chemical reactions by lowering the activation energy barrier, E_a, which is the energy required to reach the transition state from the reactants. According to the Arrhenius equation, the rate constant k of a reaction is given by k = A e^{-E_a / RT}, where A is the pre-exponential factor, R is the gas constant, and T is the temperature in Kelvin; a reduction in E_a exponentially increases the reaction rate.^[70] In enzymatic catalysis, this lowering of E_a enables reactions to proceed at biologically relevant rates and temperatures, often by orders of magnitude faster than the uncatalyzed counterparts.^[70] Transition state theory provides the thermodynamic framework for understanding this effect, positing that enzymes stabilize the transition state (TS) more tightly than the ground-state substrates or products, thereby reducing the free energy of activation, \Delta G^\ddagger. This preferential binding to the TS, first proposed by Linus Pauling, decreases \Delta G^\ddagger and thus E_a, as the enzyme's active site is complementary to the TS geometry and charge distribution.^[71]^[72] For instance, in chorismate mutase, electrostatic interactions at the active site stabilize the TS of the Claisen rearrangement, contributing up to 5.9 kcal/mol to the \Delta G^\ddagger reduction through specific residues like Arg90.^[72] The reduction in activation energy often involves both enthalpic and entropic contributions, with enzymes minimizing the entropic penalty associated with organizing reactants for reaction. In solution, reactions incur a high entropic cost due to the loss of translational and rotational freedom upon forming the reactive complex, as well as solvent reorganization energy.^[73] Enzymes counteract this through pre-organization of the active site, which is already configured to complement the TS, thereby reducing the need for large conformational adjustments and associated entropy loss during catalysis.^[73] This pre-organization effectively lowers the overall \Delta G^\ddagger by favoring enthalpic stabilization while mitigating entropic barriers, as seen in cases where the enzyme environment substitutes for solvent effects in a low-dielectric active site.^[73] A striking example is orotidine 5'-monophosphate decarboxylase (OMPDC), which catalyzes the decarboxylation of orotidine 5'-monophosphate to uridine 5'-monophosphate with a rate acceleration of approximately $10^{17}-fold compared to the uncatalyzed reaction. This enormous enhancement arises primarily from electrostatic stabilization of the vinyl anion-like transition state, where active site residues such as Lys72 position charges to delocalize the negative charge developing during decarboxylation.^[74] While additional interactions, like a hydrogen bond from Ser127 to the substrate's O4, contribute modestly (about $10^2-fold), the dominant effect is the enthalpic stabilization of the TS through electrostatic pre-organization, underscoring how enzymes exploit such mechanisms to surmount energy barriers efficiently.^[74]

Equilibrium and Reversibility

Enzymes catalyze chemical reactions by lowering the activation energy barrier, thereby accelerating the rate at which the system approaches equilibrium, but they do not alter the position of equilibrium or the standard Gibbs free energy change (ΔG°) of the reaction.^[9] The Gibbs free energy change for a reaction is given by the equation ΔG = ΔH - TΔS, where ΔH is the enthalpy change, T is the absolute temperature, and ΔS is the entropy change; enzymes influence neither the thermodynamic parameters ΔH nor ΔS, nor the resulting ΔG°, which determines the spontaneity and equilibrium constant of the reaction.^[75] Instead, enzymes facilitate the reaction along a pathway that stabilizes the transition state, allowing the system to reach the same equilibrium ratio of reactants to products more rapidly than in the uncatalyzed case.^[9] Most enzymatic reactions are reversible, meaning the enzyme can catalyze the reaction in either direction depending on substrate and product concentrations, as long as the reaction does not violate thermodynamic constraints. For instance, isomerases such as triose phosphate isomerase in glycolysis interconvert dihydroxyacetone phosphate and glyceraldehyde 3-phosphate in a readily reversible manner, with an equilibrium constant close to unity that reflects minimal free energy difference between substrates. In contrast, some reactions appear effectively irreversible under physiological conditions due to a highly negative ΔG, such as the hydrolysis of ATP to ADP and inorganic phosphate catalyzed by ATPases, where ΔG° is approximately -30.5 kJ/mol, driving the reaction overwhelmingly toward product formation and preventing significant reversal. The relationship between enzymatic kinetic parameters and thermodynamic equilibrium is encapsulated in the Haldane equation, derived from steady-state kinetics, which connects the equilibrium constant (K_eq = [P]/[S] at equilibrium) to the maximum velocities (k_cat) and Michaelis constants (K_m) for the forward and reverse reactions: K_eq = (k_cat^f / K_m^f) / (k_cat^r / K_m^r), where superscripts f and r denote forward and reverse directions.^[76] This equation demonstrates that while enzymes enhance rates through favorable kinetic constants, these parameters must align with the underlying thermodynamics to maintain the equilibrium position dictated by ΔG°.^[77] In metabolic pathways, enzymes often participate in coupled reactions to drive thermodynamically unfavorable (endergonic) steps by linking them to highly exergonic reactions, such as ATP hydrolysis, through shared intermediates that make the overall process spontaneous. For example, the endergonic synthesis of glutamine from glutamate and ammonia (ΔG° ≈ +14 kJ/mol) is coupled to ATP hydrolysis via glutamine synthetase, resulting in a net ΔG° of about -16 kJ/mol and rendering the coupled reaction effectively irreversible in the forward direction.^[78] This coupling ensures that non-spontaneous transformations proceed efficiently within cellular constraints, without enzymes altering the intrinsic ΔG° of individual steps.

Kinetics

Rate Laws

The rate of an enzyme-catalyzed reaction is defined as the velocity v = \frac{d[P]}{dt}, where [P] is the product concentration, and this rate depends on the total enzyme concentration [E], substrate concentration [S], and environmental conditions such as pH and temperature. This general rate law provides the foundation for analyzing how enzymes accelerate reactions by stabilizing transition states, though rates are ultimately constrained by thermodynamic principles governing activation energies. Enzyme reaction orders vary with substrate concentration, reflecting the saturation behavior of the enzyme active site. At saturating [S], where all enzyme molecules are bound to substrate, the reaction exhibits zero-order kinetics: the rate becomes independent of further increases in [S] and is determined solely by the enzyme's catalytic capacity, often expressed as v = k_{\text{cat}} [E]. In contrast, at low [S] where substrate binding is limiting, the reaction follows first-order kinetics, with v proportional to [S] as the probability of enzyme-substrate encounters increases linearly. These orders highlight the transition from substrate-limited to enzyme-limited regimes in typical enzyme kinetics profiles. For enzymes acting on multiple substrates, rate laws adopt more complex forms based on the binding and catalysis mechanism. Sequential mechanisms require all substrates to bind to the enzyme before any product is released; in ordered sequential mechanisms, substrates bind in a specific sequence, while random sequential allows any order, leading to rate equations that include terms for binary, ternary, and higher complexes. Ping-pong mechanisms, also known as double-displacement, involve the enzyme first binding one substrate to form and release a product, modifying the enzyme (e.g., via covalent intermediate), before the second substrate binds to the altered form; this results in parallel line patterns in double-reciprocal plots and rate laws featuring reciprocal substrate terms without cross-interaction products. These distinctions, formalized by Cleland's nomenclature, enable mechanistic diagnosis through initial velocity studies varying substrate concentrations.^[79] A key approximation in deriving enzyme rate laws is the steady-state assumption, proposed by Briggs and Haldane, which holds that during the initial phase of the reaction—before significant product accumulation or substrate depletion—the concentration of the enzyme-substrate complex [ES] remains nearly constant, such that \frac{d[ES]}{dt} \approx 0. This condition arises because the rates of ES formation and breakdown equilibrate rapidly compared to overall product formation, simplifying the differential equations for [ES] and allowing focus on initial velocities under controlled conditions. The assumption is valid when [E] << [S] and is widely applied in kinetic analyses to predict rates without solving full time-dependent systems.

Michaelis-Menten Model

The Michaelis-Menten model describes the kinetics of enzyme-catalyzed reactions involving a single substrate, providing a foundational framework for understanding how reaction velocity depends on substrate concentration. Originally proposed by Leonor Michaelis and Maud Menten in 1913 based on equilibrium assumptions for the invertase reaction, the model was refined in 1925 by George E. Briggs and J.B.S. Haldane using a steady-state approximation, which is the standard form used today.^[19]^[80] The model assumes the reaction proceeds via the formation of an enzyme-substrate (ES) complex:

E + S \underset{k_{-1}}{\stackrel{k_1}{\rightleftharpoons}} ES \stackrel{k_{\text{cat}}}{\rightarrow} E + P

where E is the enzyme, S the substrate, P the product, k_1 the association rate constant, k_{-1} the dissociation rate constant, and k_{\text{cat}} (also called k_2) the catalytic rate constant. The initial reaction velocity v is given by the Michaelis-Menten equation:

v = \frac{V_{\max} [S]}{K_m + [S]}

Here, V_{\max} is the maximum velocity achieved when the enzyme is saturated with substrate, defined as V_{\max} = k_{\text{cat}} [E]_{\text{total}}, where [E]_{\text{total}} is the total enzyme concentration; K_m is the Michaelis constant, representing the substrate concentration at which v = V_{\max}/2, and given by K_m = (k_{-1} + k_{\text{cat}})/k_1. This hyperbolic relationship indicates that velocity increases with substrate concentration but approaches V_{\max} asymptotically.^[80] The steady-state derivation begins by applying the quasi-steady-state approximation to the ES complex, assuming d[ES]/dt \approx 0 after an initial transient phase. The rate of ES formation equals its rate of depletion:

k_1 [E] [S] = (k_{-1} + k_{\text{cat}}) [ES]

Since [E] = [E]_{\text{total}} - [ES], solving for [ES] yields:

[ES] = \frac{[E]_{\text{total}} [S]}{K_m + [S]}

The velocity v = k_{\text{cat}} [ES] then substitutes to give the Michaelis-Menten equation. This approach relaxes the rapid equilibrium assumption of the original model, making it applicable to a broader range of enzymes where the catalytic step is not necessarily slow compared to dissociation.^[80] To estimate K_m and V_{\max} experimentally, the Lineweaver-Burk double-reciprocal plot linearizes the equation:

\frac{1}{v} = \frac{K_m}{V_{\max}} \cdot \frac{1}{[S]} + \frac{1}{V_{\max}}

Plotting $1/v versus $1/[S] produces a straight line with slope K_m / V_{\max}, y-intercept $1/V_{\max}, and x-intercept -1/K_m. Introduced by Hans Lineweaver and Dean Burk in 1934, this transformation facilitates parameter determination from initial rate data but can amplify errors at low substrate concentrations.^[81] The model relies on key assumptions, including measurement of initial rates where product accumulation is negligible (avoiding product inhibition or reverse reactions) and the absence of complicating factors like multiple substrates or enzyme instability. It applies well to non-allosteric enzymes but has limitations for allosteric enzymes, where cooperative substrate binding leads to sigmoidal rather than hyperbolic kinetics, as described in the Monod-Wyman-Changeux model.^[82]^[83]

Inhibition

Reversible Inhibition

Reversible inhibition occurs when an inhibitor binds non-covalently to an enzyme, forming a reversible complex that can dissociate, thereby modulating enzyme activity without permanent alteration.^[84] This type of inhibition is characterized by equilibrium binding and can be analyzed using modifications of the Michaelis-Menten kinetic model, where the inhibition constant K_i quantifies the inhibitor's affinity for the enzyme, with lower values indicating stronger binding.^[84] In competitive inhibition, the inhibitor binds exclusively to the free enzyme at the active site, competing directly with the substrate and preventing substrate binding.^[84] This increases the apparent Michaelis constant K_m while leaving the maximum velocity V_{max} unchanged, as higher substrate concentrations can outcompete the inhibitor.^[84] The modified velocity equation is:

v = \frac{V_{max} [S]}{K_m (1 + \frac{[I]}{K_i}) + [S]}

A representative example is the action of statins, such as lovastatin, which competitively inhibit HMG-CoA reductase by mimicking the substrate HMG-CoA and binding to its active site, thereby reducing cholesterol biosynthesis.^[85] Non-competitive inhibition involves the inhibitor binding to a site distinct from the active site on either the free enzyme or the enzyme-substrate complex with equal affinity, thereby reducing the enzyme's catalytic efficiency without affecting substrate binding.^[84] This decreases the apparent V_{max} but leaves K_m unchanged, as the inhibitor does not interfere with substrate affinity.^[84] The velocity equation becomes:

v = \frac{V_{max} [S]}{(K_m + [S]) (1 + \frac{[I]}{K_i})}

Heavy metals like mercury or lead exemplify non-competitive inhibitors, binding to sulfhydryl groups on enzymes such as pyruvate kinase and impairing function regardless of substrate presence.^[86] Uncompetitive inhibition is distinguished by the inhibitor binding solely to the enzyme-substrate complex, stabilizing it and preventing product formation.^[84] This results in a decrease in both apparent K_m and V_{max}, with the reduction in K_m arising from the inhibitor's enhancement of substrate affinity in the complex.^[84] The kinetic equation is:

v = \frac{V_{max} [S]}{K_m + [S] (1 + \frac{[I]}{K_i})}

Lithium serves as an uncompetitive inhibitor of inositol monophosphatase, binding to the enzyme-substrate complex and inhibiting dephosphorylation of inositol phosphates, a mechanism implicated in its therapeutic effects on bipolar disorder.^[87] Mixed inhibition encompasses cases where the inhibitor binds to both the free enzyme and the enzyme-substrate complex, but with differing affinities, combining elements of competitive and non-competitive inhibition.^[84] It alters both K_m and V_{max}, with the degree of change depending on the relative dissociation constants K_i (for free enzyme) and K_i' (for the complex).^[84] The general velocity equation is:

v = \frac{V_{max} [S]}{K_m (1 + \frac{[I]}{K_i}) + [S] (1 + \frac{[I]}{K_i'})}

The inhibition constant K_i is formally defined as the dissociation constant for the enzyme-inhibitor complex, K_i = \frac{[E][I]}{[EI]}, providing a measure of binding strength that is central to comparing inhibitor potencies across these reversible mechanisms.^[84]

Irreversible Inhibition

Irreversible inhibition occurs when an inhibitor forms a covalent bond with the enzyme, permanently inactivating it and preventing substrate binding or catalysis.^[88] This contrasts with reversible inhibition, where the inhibitor can dissociate from the enzyme.^[89] The process typically involves a two-step mechanism: an initial non-covalent binding step followed by irreversible covalent modification.^[90] A common mechanism is the nucleophilic attack by an enzyme residue, such as a serine hydroxyl group, on an electrophilic center in the inhibitor, leading to covalent adduct formation.^[91] For instance, penicillin acts as an irreversible inhibitor of bacterial DD-transpeptidase by mimicking the D-Ala-D-Ala substrate; the β-lactam ring opens upon binding, allowing the serine nucleophile to acylate the inhibitor, blocking peptidoglycan cross-linking in cell walls.^[92] The kinetics of irreversible inhibition are characterized by time-dependent loss of enzyme activity, often modeled as pseudo-first-order inactivation.^[90] The observed rate constant k_{\text{obs}} follows the equation:

k_{\text{obs}} = \frac{k_{\text{inact}} [I]}{K_I + [I]}

where k_{\text{inact}} is the maximum inactivation rate constant, [I] is the inhibitor concentration, and K_I is the dissociation constant for the initial enzyme-inhibitor complex.^[93] This hyperbolic relationship allows determination of potency through k_{\text{inact}}/K_I, a second-order rate constant reflecting overall efficiency.^[94] Representative examples include aspirin, which irreversibly acetylates Ser⁵³⁰ in the active site of cyclooxygenase-1 (COX-1), inhibiting prostaglandin synthesis and platelet aggregation.^[95] Organophosphates, such as those in pesticides, phosphorylate the active-site serine in acetylcholinesterase, preventing acetylcholine hydrolysis and causing cholinergic toxicity.^[96] Suicide inhibitors, also known as mechanism-based inhibitors, are prodrugs activated by the target enzyme's catalytic machinery to generate a reactive species that covalently modifies the enzyme.^[97] A key example is 5-fluorouracil (5-FU), metabolized to 5-fluoro-2'-deoxyuridine-5'-monophosphate (FdUMP), which forms a stable ternary complex with thymidylate synthase and 5,10-methylenetetrahydrofolate, irreversibly inhibiting the enzyme and disrupting DNA synthesis in cancer cells.^[98]

Regulation

Allosteric Effects

Allosteric effects in enzymes arise from the binding of regulatory molecules, termed effectors, to dedicated sites remote from the catalytic active site, inducing conformational changes that alter the enzyme's affinity for its substrate or its catalytic rate. This non-competitive modulation allows precise control of metabolic pathways without directly competing at the active site. Unlike simple inhibition or activation at the active site, allostery enables integrated responses to cellular signals, often in oligomeric enzymes where subunit interactions propagate the effect across the protein structure. Allosteric sites are structurally distinct from the active site, typically located at subunit interfaces or on non-catalytic domains, enabling specific recognition of effectors. A well-characterized example is aspartate transcarbamoylase (ATCase), the committed enzyme in pyrimidine biosynthesis, which consists of catalytic and regulatory subunits. Cytidine triphosphate (CTP), the pathway's end product, binds to allosteric sites on the regulatory subunits, stabilizing a low-affinity tense state and inhibiting activity by enhancing the sigmoidal response to aspartate, the substrate; this reduces enzyme velocity at physiological concentrations. In contrast, adenosine triphosphate (ATP), signaling purine abundance, binds to the same sites, competing with CTP to favor a high-affinity relaxed state and activate the enzyme. These heterotropic effects fine-tune nucleotide balance without covalent modification.^[99] Theoretical models elucidate how allosteric binding translates to functional changes. The concerted Monod-Wyman-Changeux (MWC) model describes the enzyme as existing in equilibrium between a tense (T) state of low substrate affinity and a relaxed (R) state of high affinity; all subunits transition simultaneously upon effector binding, shifting the T-R equilibrium without hybrid intermediates. This symmetry-conserving mechanism explains both homotropic substrate cooperativity and heterotropic regulation, where inhibitors stabilize the T state and activators favor the R state. Alternatively, the sequential Koshland-Némethy-Filmer (KNF) model proposes an induced-fit process: ligand binding to one subunit triggers a localized conformational change that sequentially alters adjacent subunits' affinities, allowing asymmetric intermediates and greater flexibility in cooperativity patterns. These models, while idealized, capture the essence of allosteric propagation in multisubunit enzymes.^[100]^[101] Cooperativity, a hallmark of allosteric enzymes, manifests as interdependent substrate binding sites, yielding sigmoidal kinetics that amplify responses to substrate concentration changes. The Hill equation quantifies this:

\theta = \frac{[S]^{n_H}}{K_{0.5}^{n_H} + [S]^{n_H}}

where \theta represents fractional saturation, [S] is substrate concentration, K_{0.5} is the concentration for half-maximal saturation, and n_H (the Hill coefficient) indicates cooperativity degree: n_H > 1 for positive cooperativity (enhanced binding after initial ligation), n_H < 1 for negative, and n_H = 1 for non-cooperative (Michaelis-Menten) behavior. In ATCase, for instance, n_H \approx 1.5-2 reflects moderate positive homotropic cooperativity for aspartate. Allostery distinguishes homotropic effects, where the substrate itself acts as effector to drive its own cooperativity, from heterotropic effects, where non-substrate molecules like CTP or ATP modulate independent of substrate binding. These interactions underpin sensitive regulatory switches in cellular metabolism.^[102]

Covalent Modifications

Covalent modifications represent a key mechanism for the post-translational regulation of enzyme activity, involving the addition or removal of chemical groups that can reversibly activate or deactivate enzymes through enzymatic control. These modifications allow cells to rapidly respond to signals by altering enzyme function without synthesizing new proteins.^[103] Phosphorylation is one of the most prevalent covalent modifications, where kinases transfer a phosphate group from ATP to serine, threonine, or tyrosine residues on the enzyme, often inactivating it, while phosphatases remove the phosphate to restore activity. For instance, glycogen synthase, which catalyzes glycogen synthesis, is inactivated by multi-site phosphorylation on serine residues by kinases such as cAMP-dependent protein kinase and glycogen synthase kinase-3, increasing its Km for UDP-glucose and reducing catalytic efficiency; dephosphorylation by protein phosphatase-1 reactivates it.^[103]^[104]^[105] This reversible cycle exemplifies ultrasensitive signal transduction, enabling switch-like responses to hormonal cues like glucagon or insulin.^[105] Other covalent modifications include acetylation, where acetyl groups are added to lysine residues by histone acetyltransferases (e.g., p300) and removed by deacetylases (e.g., HDACs or sirtuins), modulating enzyme activity in metabolic pathways; methylation, involving methyltransferases adding methyl groups to arginine or lysine, which can alter substrate binding or stability; and ubiquitination, where ubiquitin is attached via E1, E2, and E3 enzymes to mark enzymes for proteasomal degradation, thereby controlling protein levels and indirectly regulating activity.^[103]^[106]^[107] A notable example of irreversible covalent modification is zymogen activation, such as the proteolytic cleavage of trypsinogen to active trypsin by enteropeptidase in the duodenum, which removes an N-terminal peptide and forms stabilizing salt bridges, enabling the enzyme's catalytic function in protein digestion.^[108] In signal transduction cascades, these modifications often operate reversibly; for example, in insulin signaling, phosphorylation of downstream enzymes like glycogen synthase by insulin-stimulated kinases promotes glucose uptake, while dephosphorylation fine-tunes the response to maintain homeostasis.^[109]^[103]

Environmental Factors

Enzyme activity is profoundly influenced by environmental pH, which modulates the ionization states of catalytic amino acid residues such as histidine, aspartate, and glutamate in the active site.^[9] Deviations from the optimal pH can protonate or deprotonate these residues, disrupting substrate binding or catalysis. For instance, pepsin, a protease in the gastric environment, exhibits maximal activity at pH 1.5–2, where acidic conditions facilitate its function in protein digestion.^[110] In contrast, alkaline phosphatase, involved in phosphate ester hydrolysis, achieves peak activity at pH 9–10, reflecting adaptation to alkaline cellular or extracellular compartments.^[111] The pH dependence typically manifests as a bell-shaped activity curve, with the optimum corresponding to the average pKa of key ionizable groups; activity declines sharply outside this range due to altered electrostatic interactions.^[9] Temperature exerts a dual effect on enzymes, initially enhancing reaction rates through increased molecular collisions and kinetic energy, as described by the Arrhenius equation, which relates the rate constant k to temperature T via k = A e^{-E_a / RT}, where A is the pre-exponential factor, E_a is the activation energy, and R is the gas constant.^[112] Most mammalian enzymes operate optimally near 37°C, but exceeding this threshold leads to thermal denaturation, where hydrophobic interactions and hydrogen bonds weaken, causing irreversible unfolding and loss of native structure.^[112] Thermostable enzymes, such as Taq DNA polymerase from Thermus aquaticus, maintain activity up to 72–80°C, enabling applications like PCR due to their resistance to denaturation.^[113] Ionic strength and specific salts impact enzyme function by modulating electrostatic forces within the protein and between the enzyme and substrate. Higher ionic strength can screen charges, stabilizing folded states or alleviating repulsion in active sites, though excessive levels may disrupt salt bridges.^[114] Divalent cations like Ca²⁺ often serve as essential cofactors, binding to specific sites to rigidify structures or participate in catalysis; for example, phospholipase A₂ requires Ca²⁺ for interfacial activation and phospholipid hydrolysis.^[115] Monovalent ions such as Na⁺ or K⁺ can activate certain enzymes at low concentrations by facilitating conformational changes, but inhibitory effects emerge at higher levels.^[114] Denaturation represents a critical environmental perturbation, particularly from heat, resulting in irreversible unfolding that exposes hydrophobic cores and promotes aggregation. The melting temperature (T_m), defined as the midpoint where 50% of the protein population is unfolded, quantifies thermal stability and is measured via techniques like differential scanning calorimetry.^[116] For many enzymes, T_m values range from 40–60°C, but engineered or thermophilic variants exceed 80°C, correlating with enhanced hydrogen bonding and hydrophobic packing.^[116] Once denatured, recovery of activity is rare without chaperones, underscoring the importance of physiological temperature homeostasis.^[117]

Biological Functions

Metabolic Pathways

Enzymes are integral to metabolic pathways, orchestrating the transformation of substrates in interconnected catabolic and anabolic networks that support cellular energy production and biosynthesis. In the glycolytic pathway, which converts glucose to pyruvate under anaerobic conditions, ten distinct enzymes catalyze sequential reactions, with hexokinase initiating the process by phosphorylating glucose to glucose-6-phosphate. This pathway exemplifies how enzymes enable efficient breakdown of carbohydrates, yielding ATP and NADH for cellular use.^[118]^[119] The tricarboxylic acid (TCA) cycle, a core amphibolic pathway in aerobic respiration, relies on eight enzymes to oxidize acetyl-CoA derived from glycolysis or fatty acid breakdown, generating reducing equivalents for the electron transport chain. Citrate synthase, the first enzyme, catalyzes the condensation of acetyl-CoA with oxaloacetate to produce citrate, linking upstream catabolism to downstream energy yield. In autotrophic organisms, photosynthetic pathways such as the Calvin-Benson-Bassham cycle depend on enzymes like ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), which fixes atmospheric CO2 into 3-phosphoglycerate, facilitating carbon assimilation and the synthesis of sugars.^[120]^[121]^[122] Metabolic flux through these pathways is tightly controlled by rate-limiting enzymes that dictate overall throughput based on substrate availability and energy demands. For example, phosphofructokinase in glycolysis catalyzes the irreversible phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate, serving as a primary regulatory point to prevent unnecessary glucose consumption when energy is abundant. Such control ensures balanced integration of catabolic and anabolic processes across cellular compartments.^[123]^[124] Spatial compartmentalization enhances pathway efficiency and specificity, with glycolytic enzymes localized in the cytosol to rapidly process cytoplasmic glucose, while TCA cycle enzymes reside in the mitochondrial matrix, coupling oxidation to oxidative phosphorylation. This segregation prevents interference between pathways and optimizes metabolite gradients. Multi-enzyme complexes, known as metabolons, further streamline reactions; the pyruvate dehydrogenase complex, bridging glycolysis and the TCA cycle, assembles multiple subunits to channel pyruvate-derived acetyl-CoA directly to citrate synthase, minimizing diffusion losses and intermediate exposure. Regulation mechanisms briefly coordinate these pathways to synchronize flux with cellular needs.^[125]^[126]^[127]

Cellular Control Mechanisms

Cells maintain metabolic homeostasis through precise control of enzyme availability and positioning, ensuring that catalytic activities align with cellular demands. One primary mechanism involves transcriptional regulation of enzyme gene expression, where environmental signals modulate the synthesis of specific enzymes. For instance, in bacteria, the lac operon exemplifies inducible expression: in the presence of lactose, the lac repressor protein dissociates from the operator region, allowing RNA polymerase to transcribe genes encoding β-galactosidase, lactose permease, and thiogalactoside transacetylase, thereby enabling lactose metabolism only when glucose is scarce.^[128] Enzyme protein levels are further regulated post-transcriptionally by balancing synthesis and degradation rates. Protein synthesis rates are influenced by translational efficiency and mRNA stability, while degradation primarily occurs via the ubiquitin-proteasome pathway, where enzymes targeted for turnover are polyubiquitinated and degraded by the 26S proteasome complex. This selective degradation prevents accumulation of unnecessary or damaged enzymes, maintaining optimal concentrations. Additionally, molecular chaperones, such as Hsp70 and GroEL/GroES, assist in proper folding of newly synthesized enzymes, preventing aggregation and ensuring functional maturation; misfolded enzymes may be directed to degradation pathways if refolding fails.^[129] Subcellular localization restricts enzyme activity to specific compartments, enhancing efficiency and preventing off-target effects. Lysosomal hydrolases, like acid phosphatases and cathepsins, are trafficked to lysosomes via mannose-6-phosphate receptors in the Golgi apparatus, where they function optimally in the acidic lumen to degrade macromolecules. Scaffolding proteins further organize enzymes into multi-enzyme complexes or signaling hubs, localizing them to precise cellular locales; for example, A-kinase anchoring proteins (AKAPs) tether protein kinase A and phosphatases to maintain localized cAMP signaling, indirectly influencing enzyme regulation.^[130] Feedback loops provide dynamic control by integrating enzyme activity with pathway outputs, particularly through product inhibition. In metabolic pathways, end products often bind to upstream enzymes, allosterically inhibiting their activity to prevent overproduction; a classic case is the inhibition of aspartate transcarbamoylase by CTP in pyrimidine biosynthesis, which halts the pathway when nucleotide levels are sufficient. These mechanisms collectively ensure that enzyme quantities and localizations adapt to maintain balanced metabolism across cellular contexts.

Pathological Roles

Enzyme deficiencies arising from genetic mutations can lead to severe pathological conditions by disrupting critical metabolic processes. Phenylketonuria (PKU), an autosomal recessive disorder, results from mutations in the PAH gene, causing a deficiency in phenylalanine hydroxylase (PAH), the enzyme responsible for converting phenylalanine to tyrosine; this leads to toxic accumulation of phenylalanine, resulting in intellectual disability, seizures, and behavioral issues if untreated.^[131] Lysosomal storage diseases, such as Gaucher disease, exemplify another category of enzyme deficiencies, where mutations in the GBA1 gene impair glucocerebrosidase activity, causing accumulation of glucocerebroside in lysosomes; this manifests as hepatosplenomegaly, anemia, thrombocytopenia, and bone pain in type 1 Gaucher disease, with neurological involvement in types 2 and 3.^[132] In cancer, enzyme overactivity often drives uncontrolled cell proliferation and immortality. Telomerase, a ribonucleoprotein enzyme that maintains telomere length, is reactivated and overexpressed in approximately 90% of human cancers, enabling limitless replicative potential and tumor progression by preventing telomere shortening-induced senescence.^[133] Similarly, oncogenic kinases like BCR-ABL, a fusion tyrosine kinase resulting from the Philadelphia chromosome translocation, constitutively activate signaling pathways in chronic myeloid leukemia (CML), promoting leukemic cell survival, proliferation, and resistance to apoptosis.^[134] Therapeutic strategies targeting pathological enzyme activities have revolutionized treatment for enzyme-related diseases. Enzyme inhibitors, such as imatinib, a selective tyrosine kinase inhibitor, bind to the BCR-ABL kinase domain and block its ATP-binding site, inducing remission in over 90% of CML patients by halting aberrant signaling.^[135] For deficiencies, enzyme replacement therapy (ERT) delivers recombinant enzymes intravenously; in Gaucher disease, imiglucerase (recombinant glucocerebrosidase) reduces substrate accumulation, alleviating visceral and skeletal symptoms.^[136] Advanced approaches include antibody-linked enzymes in antibody-directed enzyme prodrug therapy (ADEPT), where tumor-targeted antibodies conjugate enzymes like carboxypeptidase to activate non-toxic prodrugs selectively at cancer sites, minimizing systemic toxicity.^[137] Enzymes also serve as biomarkers for diagnosing pathological conditions through their abnormal levels in bodily fluids. Elevated creatine kinase-MB (CK-MB), a cardiac-specific isoenzyme, in serum indicates myocardial infarction, rising within 3-6 hours of injury due to cardiomyocyte necrosis and peaking at 16-30 hours, aiding rapid diagnosis when combined with troponins.^[138]

Evolution

Origins and Ancestry

The evolutionary origins of enzymes trace back to prebiotic chemistry on early Earth, where simple catalytic molecules likely facilitated the emergence of life before the dominance of protein-based enzymes. In the proposed RNA world hypothesis, RNA molecules served as both genetic material and catalysts, known as ribozymes, which performed essential reactions without protein assistance. These ribozymes are considered precursors to modern enzymes, enabling self-replication and basic metabolism in a pre-protein era.^[139]^[140] A prominent example is the peptidyl transferase center of the ribosome, which functions as a ribozyme to catalyze peptide bond formation during protein synthesis, suggesting that RNA-based catalysis predated the protein world.^[141] Genomic and fossil evidence places the timeline of enzyme origins around 4 billion years ago, coinciding with the formation of the first cellular life forms shortly after Earth's oceans stabilized. This period aligns with the appearance of the last universal common ancestor (LUCA), a hypothetical progenitor from which all extant life descends, possessing a core set of enzymes essential for basic cellular functions. Notably, ATP synthase, which generates ATP via proton gradients across membranes, is conserved across bacterial and archaeal domains and is inferred to have been present in LUCA, indicating its ancient role in energy conservation.^[142]^[143]^[144] Throughout evolutionary history, horizontal gene transfer has significantly influenced enzyme distribution, allowing rapid dissemination of catalytic capabilities across microbial lineages. For instance, genes encoding enzymes that confer antibiotic resistance, such as beta-lactamases, have spread via plasmids and other mobile elements, accelerating adaptation in response to environmental pressures. This mechanism highlights how enzyme evolution extended beyond vertical inheritance, shaping microbial diversity from early prokaryotic communities. Modern enzyme structures often retain ancient protein folds, echoing these primordial catalytic motifs.^[145]^[146]

Adaptive Diversification

Enzymes achieve adaptive diversification through evolutionary mechanisms that enable the emergence of new functions, primarily via gene duplication, promiscuity, moonlighting, and laboratory-directed evolution, allowing organisms to respond to changing environmental pressures and metabolic demands. Gene duplication events provide a key substrate for this process by creating paralogous copies that initially retain the original function but face relaxed selective constraints, permitting mutations to accumulate without immediate fitness costs. This can lead to neofunctionalization, where one copy evolves a novel catalytic activity while the other maintains the ancestral role, thereby expanding the enzyme repertoire without disrupting existing pathways.^[147] In the alpha-amylase family, gene duplications have driven neofunctionalization, resulting in diverse starch-degrading enzymes adapted to specific ecological niches, such as the evolution of beta-amylases in angiosperms that exhibit sub- or neo-functionalization through extensive duplication events across eight distinct clades. These duplications allow for specialization, for instance, in hydrolyzing different glycosidic bonds under varying conditions like temperature or pH in plant and microbial lineages. Similarly, promiscuity in ancestral enzymes—characterized by low substrate specificity—serves as an evolutionary starting point, enabling weak side activities to be refined into high-efficiency new functions under selective pressure, as seen in the transition from generalist hydrolases to specialized lipases or esterases. This promiscuous foundation facilitates innovation by providing latent catalytic potential that can be co-opted for novel metabolisms.^[148]^[149] Moonlighting enzymes further exemplify adaptive versatility, where a single protein performs multiple, often unrelated functions depending on cellular context, such as localization or binding partners, without requiring sequence divergence. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), primarily involved in glycolysis, also acts in apoptosis by translocating to the nucleus to bind DNA and promote cell death signaling, a role that enhances cellular control mechanisms in response to stress. This multifunctionality arises evolutionarily from structural features that allow conformational flexibility, enabling the enzyme to switch roles without gene duplication. In laboratory settings, directed evolution mimics these natural processes by iteratively applying random mutagenesis and selection to engineer enzymes with desired properties, as demonstrated by Frances Arnold's development of cytochrome P450 variants capable of stereoselective cyclopropanation, achieving up to 99% enantioselectivity for non-natural reactions like carbene transfer to alkenes. These engineered P450s, derived from promiscuous ancestors, illustrate how targeted selection can rapidly diversify enzyme functions for biotechnological applications.^[150]^[151]

Applications

Industrial Processes

Enzymes play a pivotal role in industrial processes by enabling efficient, sustainable manufacturing through biocatalysis, which often reduces energy consumption and minimizes environmental impact compared to traditional chemical methods.^[152] In sectors like food production, biofuels, and pharmaceuticals, enzymes facilitate large-scale transformations of raw materials into valuable products, enhancing yield and product quality while allowing for milder reaction conditions.^[153] In the food industry, amylases are widely employed to hydrolyze starch into simpler sugars, improving processing efficiency. In baking, α-amylases break down starch in dough to produce dextrins, resulting in better bread volume, texture, and shelf life by acting as antistaling agents.^[154] Similarly, in brewing, these enzymes convert barley starches into fermentable sugars during mashing, boosting ethanol yield and enabling the production of lighter beers with reduced calories through glucoamylase action on dextrins.^[154] Rennet, primarily chymosin from microbial sources, is essential for cheese production, where it hydrolyzes κ-casein in milk to promote coagulation and curd formation, accelerating ripening and enhancing flavor development.^[154] Lipases find application in detergent formulations to degrade lipid-based stains, improving cleaning performance in laundry processes, though they also contribute to flavor enhancement in dairy products like cheese by liberating free fatty acids.^[154] For biofuel production, cellulases are critical in breaking down lignocellulosic biomass into fermentable sugars for ethanol synthesis. These enzyme cocktails, including endoglucanases, exoglucanases, and β-glucosidases, hydrolyze pretreated plant materials like corn stover, with companies such as Novonesis (formed by the 2024 merger of Novozymes and Chr. Hansen) developing optimized formulations that have contributed to reducing production costs, with minimum fuel selling prices averaging $2.65 per gallon (range $0.90–$6.00/gallon) as of recent analyses through improved yields and stability.^[155]^[156] In pharmaceutical manufacturing, penicillin acylase catalyzes the hydrolysis of penicillin G to produce 6-aminopenicillanic acid (6-APA), a key intermediate for semisynthetic β-lactam antibiotics like amoxicillin.^[157] This enzymatic process offers high specificity and efficiency, replacing harsher chemical methods and enabling scalable synthesis of antibiotics with minimal byproducts.^[157] To enhance economic viability, enzyme immobilization techniques are routinely applied in these industries, allowing repeated use and recovery. Adsorption involves reversible binding of enzymes to solid supports like ion-exchange resins, offering simplicity and low cost but risking desorption under operational stresses.^[158] Entrapment, by contrast, confines enzymes within polymer matrices such as alginate beads or gels, providing robust protection and high loading but potentially introducing diffusion limitations that reduce reaction rates.^[158] Key challenges include maintaining enzymatic stability against thermal denaturation, pH shifts, and mechanical shear during prolonged reuse, which can limit operational cycles and overall productivity.^[158] Engineered enzymes, optimized for such immobilization, further improve process robustness in industrial settings.^[158]

Biomedical Uses

Enzymes play a pivotal role in biomedical diagnostics through techniques that leverage their catalytic properties for sensitive detection of biomolecules. In enzyme-linked immunosorbent assays (ELISA), horseradish peroxidase (HRP) is commonly conjugated to antibodies to amplify signals via chromogenic or fluorescent substrates, enabling the quantification of antigens or antibodies at picomolar levels in clinical samples such as blood or serum.^[159] This method has become a cornerstone for diagnosing infectious diseases, autoimmune disorders, and cancers, with HRP's high turnover rate allowing for rapid readout in under an hour.^[160] In therapeutics, enzymes are administered to replace deficient activities or target pathological processes. For cystic fibrosis, alginate lyase has been investigated as an enzyme replacement therapy to degrade alginate biofilms produced by Pseudomonas aeruginosa in lung mucus, potentially improving mucociliary clearance and reducing infection severity in preclinical models.^[161] Similarly, thrombolytic enzymes like streptokinase activate plasminogen to plasmin, dissolving fibrin clots in acute myocardial infarction or pulmonary embolism, achieving reperfusion in approximately 65% of cases when administered promptly.^[162] These applications draw from pathological roles where enzyme dysregulation contributes to disease, informing targeted interventions.^[163] Emerging biotechnologies harness engineered enzymes for precise genetic and metabolic modifications. The CRISPR-Cas9 system utilizes the Cas9 nuclease enzyme, developed in 2012, to create targeted double-strand breaks in DNA guided by RNA, facilitating gene editing for treating genetic disorders like sickle cell disease and certain cancers in clinical trials.^[164] Directed evolution techniques iteratively mutate and select cytochrome P450 enzymes—key drug-metabolizing proteins—to enhance their specificity and stability, enabling personalized medicine applications such as detoxifying xenobiotics or optimizing prodrug activation in vivo.^[165] Despite these advances, enzyme therapeutics face challenges including immunogenicity and delivery barriers. Foreign enzymes can elicit antibody responses, reducing efficacy and causing hypersensitivity, as observed in 1.6% to 4.4% of patients receiving streptokinase from major clinical trials.^[166] To mitigate this, PEGylation—covalent attachment of polyethylene glycol—extends plasma half-life from minutes to days and masks immunogenic epitopes, as demonstrated in approved therapies like pegademase for adenosine deaminase deficiency.^[167] In the 2020s, progress with mRNA-encoded enzymes, such as transient expression of Cas9 via lipid nanoparticles, circumvents immunogenicity by leveraging the patient's cellular machinery, showing promise in phase I trials for liver-directed editing without persistent protein exposure, with updated data confirming safety as of 2025.^[168]^[169]

References

[1]
Enzyme - National Human Genome Research Institute
An enzyme is a biological catalyst that is usually a protein but could be RNA. The point of a catalyst is to increase the speed with which a reaction happens.
[2]
RNA catalysis—is that it? - PMC - PubMed Central - NIH
Ribozymes are RNA molecules that accelerate chemical reactions, enzymes that happen to be made of RNA rather than protein.
[3]
Biochemistry, Proteins Enzymes - StatPearls - NCBI Bookshelf - NIH
Enzymes are proteins that act upon substrate molecules and decrease the activation energy necessary for a chemical reaction to occur by stabilizing the ...
[4]
Enzymes | Idaho State University
Enzymes are biological catalysts, compounds that speed up chemical reactions without being used up or altered in the reaction.
[5]
Enzyme nomenclature and classification: the state of the art - PubMed
There were originally six recognized groups of enzymes: Oxidoreductases (EC 1), Transferases (EC 2), Hydrolases (EC 3), Lyases (EC 4), Isomerases (EC 5) and ...
[6]
[PDF] Enzyme Nomenclature
Enzymes are classified into six different groups according to the reaction being catalyzed. The nomenclature was determined by the Enzyme Commission in 1961 ...
[7]
Looking Back: A Short History of the Discovery of Enzymes and How ...
In this review, the origin of modern biocatalysis is summarized (Figure 1), starting with the discovery of enzymes, and exploring the principles of ...
[8]
A Broader View: Microbial Enzymes and Their Relevance in ... - NIH
In 1833, French chemist Anselme Payen discovered the first enzyme, diastase [4]. In 1835, the hydrolysis of starch by diastase was acknowledged as a catalytic ...
[9]
Enzymes: principles and biotechnological applications - PMC
Enzymes are biological catalysts (also known as biocatalysts) that speed up biochemical reactions in living organisms. They can also be extracted from cells and ...
[10]
The history of biocatalysis - Nobel Prize
1877, Wilhelm Kuhne, Germany introduces the term “enzyme” and distinguishes between enzymes and bacteria. ; 1893, Wilhelm Ostwald, Latvia classifies enzymes as ...Missing: etymology | Show results with:etymology
[11]
History of Enzyme Chemistry - Cornish‐Bowden - Wiley Online Library
May 16, 2011 · Justus von Liebig, for example, did not accept that yeast was a living organism, ridiculing those who did, and arguing that fermentation ...
[12]
A Brief History of Fermentation, East and West - SoyInfo Center
... Justus von Liebig, J.J. Berzelius, and Friedrich Woehler. This view seemed ... From that time on the term "enzyme" came to be applied to all ferments.
[13]
Eduard Buchner – Facts - NobelPrize.org
In 1897 Eduard Buchner discovered that yeast extract with no living yeast fungi can form alcohol from a sugar solution. The conclusion was that biochemical ...Missing: organized soluble
[14]
Fermented Cereal-based Products: Nutritional Aspects, Possible ...
The etymology of the term fermentation comes from the Latin verb “fevere”, which means “to boil”. Fermentation is one of the oldest known food processing ...
[15]
Enzyme Power | Current History | University of California Press
Nov 1, 2023 · It was gradually regularized by the coining of the term enzyme in the 1860s and the decisive demonstration in 1897 that enzymes, though the ...
[16]
https://online.ucpress.edu/currenthistory/article/122/847/283/197492/Enzyme-Power
[17]
https://www.nobelprize.org/prizes/chemistry/1907/buchner/lecture/
[18]
Translation of the 1913 Michaelis-Menten Paper - PMC - NIH
Michaelis and Menten tested the postulate that the rate of an enzyme-catalyzed reaction could be described by a constant term (c) multiplied by the ...
[19]
Press release: The 1989 Nobel Prize in Chemistry - NobelPrize.org
This year's Nobel Prize in chemistry has been awarded to Sidney Altman, USA and Thomas Cech, USA for their discovery that RNA (ribonucleic acid) in living ...
[20]
Frances H. Arnold – Facts – 2018 - NobelPrize.org
In 1993, Arnold conducted the first directed evolution of enzymes, which are proteins that catalyze chemical reactions. The uses of her results include more ...
[21]
[PDF] Current IUBMB recommendations on enzyme nomenclature and ...
Mar 27, 2014 · To overcome the risk of imminent chaos, the IUB set up the Enzyme Commission in 19566 which presented its Report in 1961 (IUB, 1961), in ...
[22]
[PDF] A Brief Guide to Enzyme Nomenclature and Classification - IUBMB
Enzymes are classified by EC numbers, based on the substrates transformed and products formed, and divided into 6 major classes and 7 total.
[23]
1.1.1.1 alcohol dehydrogenase - Expasy - ENZYME
ENZYME entry: EC 1.1.1.1 · Acts on primary or secondary alcohols or hemi-acetals with very broad specificity; however the enzyme oxidizes methanol much more ...
[24]
About ExplorEnz — The Enzyme Database
There are currently over 8300 entries, and proposed additions and amendments to the Enzyme Nomenclature list are made available on this site for public review ...
[25]
Enzyme Classification - IUBMB Nomenclature
To produce usable systematic names, accepted trivial names of substrates forming part of the enzyme names should be used. Where no accepted and convenient ...
[26]
Enzyme Nomenclature
Oct 20, 2025 · This page contains general information on enzyme nomenclature. It includes links to individual documents, and the number of these will increase as more ...Missing: establishment 1956
[27]
ECOD: An Evolutionary Classification of Protein Domains - PMC - NIH
Dec 4, 2014 · Here we introduce the ECOD (Evolutionary Classification Of protein Domains) database. Our goal is threefold: (1) to construct a comprehensive ...
[28]
Enzyme nomenclature and classification: the state of the art
Nov 12, 2021 · Systematic names can be quite long and complicated. An example is the systematic name for the enzyme riboflavin synthase (EC 2.5.1.9), 6,7 ...
[29]
The Anfinsen Dogma: Intriguing Details Sixty-Five Years Later - NIH
Jul 14, 2022 · The pioneering experiments of Anfinsen on the oxidative folding of RNase have been revisited discovering some details, which update the statement of his dogma.
[30]
The Shape and Structure of Proteins - Molecular Biology of the Cell
The full three-dimensional organization of a polypeptide chain is sometimes referred to as the protein's tertiary structure, and if a particular protein ...
[31]
Biochemistry, Tertiary Protein Structure - StatPearls - NCBI Bookshelf
This structure encompasses four levels—primary, secondary, tertiary, and quaternary, each contributing to the overall shape and function of the protein. Primary ...
[32]
The TIM-barrel fold: a versatile framework for efficient enzymes
Mar 16, 2001 · Recent studies on triosephosphate isomerase (TIM)-barrel enzymes highlight the remarkable versatility of the TIM-barrel scaffold.
[33]
An Ancient Fingerprint Indicates the Common Ancestry of Rossmann ...
Mar 3, 2016 · The Rossmann fold is one of the most ancient and functionally diverse protein folds, and most Rossmann enzymes utilize nucleoside-based ...
[34]
The history of the CATH structural classification of protein domains
This article presents a historical review of the protein structure classification database CATH. Together with the SCOP database, CATH remains comprehensive ...
[35]
SCOP: a Structural Classification of Proteins database - PMC - NIH
The Structural Classification of Proteins (SCOP) database provides a detailed and comprehensive description of the relationships of known protein structures.
[36]
Molecular Docking: From Lock and Key to Combination Lock - NIH
In 1894, Emil Fischer suggested that the specificity of an enzyme ... lock and key' model. Koshland's suggestion was that active sites of enzymes ...
[37]
Application of a Theory of Enzyme Specificity to Protein Synthesis ...
derived from the induced-fit theory of specificity. For example, Figure 2 shows a possible sequence of reactions in the formation of a peptide bondin the ...
[38]
The Key–Lock Theory and the Induced Fit Theory - Koshland - 1995
Jan 3, 1995 · The new theory proposed by DE Koshland, Jr. in 1958 allows one to explain regulation and cooperative effects, and adds some new specificity principles as well.
[39]
Key difference between transition state stabilization and ground ...
2.2. Enzyme–substrate noncovalent interactions that modulate ΔG‡s. For an enzyme to catalyze the reaction of a substrate, the substrate enters the enzyme ...<|separator|>
[40]
Role of non-covalent enzyme-substrate interactions in the reaction ...
The data show that hydrogen-bonding interactions between the 1-OH and 4-OH and charged groups on the enzyme stabilize the ground-state ternary complex of the ...
[41]
Titration ELISA as a Method to Determine the Dissociation Constant ...
Feb 15, 2018 · The dissociation constant describes the interaction between two partners in the binding equilibrium and is a measure of their affinity.
[42]
Simple methods to determine the dissociation constant, Kd - PMC
Sep 16, 2024 · Kd is the dissociation constant, indicating the concentration of enzyme at which 50% of the DNA is bound.
[43]
The Central Role of Enzymes as Biological Catalysts - The Cell - NCBI
Moreover, the transition state is stabilized by its tight binding to the enzyme, thereby lowering the required energy of activation.
[44]
Chapter 7: Catalytic Mechanisms of Enzymes - Chemistry
Electrostatic catalysis occurs when the enzyme active site stabilizes the transition state of the reaction by forming electrostatic interactions with the ...
[45]
Design of activated serine-containing catalytic triads with atomic ...
Serine hydrolases utilize a conserved nucleophilic serine to hydrolyze ester, amide or thio-ester bonds in proteins and small molecules and constitute one of ...
[46]
Another Look at the Mechanisms of Hydride Transfer Enzymes ... - NIH
YADH catalyzes the oxidation of alcohols to aldehydes using the coenzyme nicotinamide adenine dinucleotide (NAD).
[47]
How an enzyme surmounts the activation energy barrier - PNAS
Enzymes are powerful catalysts, some accelerating their target reactions by factors that can exceed 1020 (4). Chorismate mutases accelerate their target ...
[48]
Deep learning-based kcat prediction enables improved enzyme ...
Jun 16, 2022 · The enzyme turnover number (kcat), which defines the maximum chemical conversion rate of a reaction, is a critical parameter for understanding ...
[49]
Molecular mechanism of glycolytic flux control intrinsic to ... - PNAS
Dec 10, 2021 · The phosphotransfer reaction proceeds by adopting a fully closed conformation through the hinge-bending motion demonstrated by small-angle X-ray ...
[50]
Yeast hexokinase in solution exhibits a large conformational change ...
Yeast hexokinase in solution exhibits a large conformational change upon binding glucose or glucose 6-phosphate. Click to copy article linkArticle link copied!
[51]
Illuminating the mechanistic roles of enzyme conformational dynamics
Many enzymes mold their structures to enclose substrates in their active sites such that conformational remodeling may be required during each catalytic ...
[52]
On the Roles of Substrate Binding and Hinge Unfolding in ... - NIH
We characterized the conformational change of adenylate kinase (AK) between open and closed forms by conducting five all-atom molecular-dynamics simulations.Missing: hexokinase | Show results with:hexokinase
[53]
Probing conformational dynamics of an enzymatic active site ... - PNAS
Dec 8, 2016 · Here we report our study on the conformational dynamics of horseradish peroxidase using single-molecule multiparameter photon time-stamping spectroscopy with ...Sign Up For Pnas Alerts · Results · Enzymatic Reaction Essay
[54]
Resolving the complex role of enzyme conformational dynamics in ...
We show that Kramers' rate theory can be used to present a clear rationale of how ECD affects the reaction dynamics and catalytic rates.
[55]
Protein conformational dynamics in the mechanism of HIV-1 ... - PNAS
Dec 8, 2011 · We show that conformational isomerization in the flaps is correlated with structural reorganization of residues in the active site.
[56]
Role of Conformational Fluctuations in the Enzymatic Reaction of ...
The emergence of compensatory drug-resistant mutations in HIV-1 protease challenges the common view of the reaction mechanism of this enzyme.
[57]
The Fe and Zn cofactor dilemma - PMC - PubMed Central
1. Introduction. Metal ions are critical and ubiquitous inorganic cofactors in biological systems, occurring in more than one-third of known proteins.
[58]
Elucidating the role of metal ions in carbonic anhydrase catalysis
Sep 11, 2020 · The catalytic zinc ion in CA II serves as a Lewis acid; its primary role is to lower the pKa of the Zn-bound water from 10 to 7, allowing the ...
[59]
Magnesium induced structural reorganization in the active site ... - NIH
Aug 9, 2024 · Magnesium optimizes the angle defining the nucleophilic attack of substrates in phosphoryl transfer catalyzed by adenylate kinase.
[60]
Redox properties of cytochrome c - PubMed
The redox properties of cytochromes (cyt) c, a ubiquitous class of heme-containing electron transport proteins, have been extensively investigated over the ...
[61]
Wilson Disease - StatPearls - NCBI Bookshelf - NIH
Apr 3, 2025 · In Wilson disease, dysfunctional ATP7B leads to copper accumulation in the liver, and ceruloplasmin is secreted in a form that lacks copper and ...
[62]
[PDF] Chapter 23: Coenzymes
• many enzymes are inactive without cofactors. • cofactors are 1) metal ions or 2) coenzymes. • coenzymes - organic molecules, derived from vitamins ... examples ...
[63]
[PDF] Mechanisms of actions of coenzymes
A portion of ATP molecule which is transferred to the vitamin is the group which binds the coenzyme for the enzyme active centers. Vitamins soluble in water are ...
[64]
Enzymology below 200 K: The kinetics and thermodynamics ... - PNAS
... activation energy was calculated by using the Arrhenius equation: ln k = (−Eact/RT) + c, [2]. where k is the rate constant, Eact is the activation energy, R ...
[65]
Molecular Architecture and Biological Reactions - ACS Publications
Answers to many basic problems of biology—nature of growth, mechanism of duplication of viruses and genes, action of enzymes, mechanism, of physiological ...
[66]
Electrostatic transition state stabilization rather than reactant ... - PNAS
For more than half a century, transition state theory has provided a useful framework for understanding the origins of enzyme catalysis.
[67]
https://www.ncbi.nlm.nih.gov/books/NBK441990/
[68]
Investigating the role of a backbone to substrate hydrogen bond in ...
Oct 1, 2014 · Orotidine 5′-monophosphate decarboxylase has attracted intense enzymological interest, because it achieves a very large rate enhancement ...
[69]
Gibbs Free Energy of Activation - an overview | ScienceDirect Topics
2 Chemical and Biochemical Catalysis: The Enzymes. Catalysts accelerate the reactions by decreasing the Gibbs energy of activation without affecting equilibrium ...
[70]
A Note on the Kinetics of Enzyme Action - PubMed
A Note on the Kinetics of Enzyme Action. Biochem J. 1925;19(2):338-9. doi: 10.1042/bj0190338. Authors. G E Briggs , J B Haldane. Affiliation.Missing: equilibrium | Show results with:equilibrium
[71]
(PDF) Review of the 1925 Briggs-Haldane Enzyme Kinetics Paper ...
Jul 28, 2022 · This preprint is a brief note reviewing the contents of a 1925 paper by Briggs and Haldane that introduced the concept of steady-state conditions in enzyme ...
[72]
Basics of Metabolic Reactions - PMC - NIH
Endergonic reactions can also be coupled to exergonic reactions involving NADH, FADH2, and NADPH conversion into NAD+, FAD, and NADP+, respectively.
[73]
The kinetics of enzyme-catalyzed reactions with two or more ...
A nomenclature is proposed to facilitate discussion of possible mechanisms for enzyme-catalyzed reactions with more than one substrate or product.
[74]
A Note on the Kinetics of Enzyme Action - PMC - NIH
A Note on the Kinetics of Enzyme Action · View on publisher site · PDF (147.8 KB) · Cite · Collections · Permalink. PERMALINK. Copy ...
[75]
The Determination of Enzyme Dissociation Constants
Hans Lineweaver · Dean Burk. ACS Legacy Archive. Open PDF. Journal of the American Chemical Society. Cite this: J. Am. Chem. Soc. 1934, 56, 3, 658–666. Click to ...
[76]
A guide to the Michaelis–Menten equation: steady state and beyond
Jul 16, 2021 · Subsequently, G.E. Briggs and J.B.S. Haldane derived the equation with steady-state assumptions and this is the version that we popularly ...
[77]
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE ...
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. J Mol Biol. 1965 May:12:88-118. doi: 10.1016/s0022-2836(65)80285-6.
[78]
Mechanism of Action Assays for Enzymes - NCBI
May 1, 2012 · Types of Inhibition. There are three main types of inhibition (competitive, noncompetitive, and uncompetitive) that are most commonly used to ...
[79]
Discovery of a potent HMG-CoA reductase degrader that eliminates ...
Dec 3, 2018 · Statins act by competitively binding to the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase, HMGCR) and ...
[80]
Non-Competitive Inhibition - an overview | ScienceDirect Topics
The inhibitory effects of heavy metals, and of cyanide on cytochrome oxidase and of arsenate on glyceraldehyde phosphate dehydrogenase, are examples of non- ...
[81]
an example of uncompetitive inhibition and its pharmacological ...
The first indications that lithium may inhibit inositol monophosphatase in oivo came from AIlison, Sherman and col- leagues (see Ref. 13 for a review). Plasma ...
[82]
Assessment of Enzyme Inhibition: A Review with Examples from the ...
This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are ...
[83]
Strategies for discovering and derisking covalent, irreversible ...
This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging ...
[84]
Demystifying Functional Parameters for Irreversible Enzyme Inhibitors
Irreversible enzyme inhibitors typically operate through a two-step mechanism that involves initial reversible binding of the inhibitor to form E·I, governed k ...
[85]
Penicillin - StatPearls - NCBI Bookshelf - NIH
The catalyst for this reaction is penicillin-binding proteins, such as the enzyme DD-transpeptidase. Penicillin's 4-membered β-lactam ring can bind to DD ...
[86]
The mechanism of action of penicillin. Penicillin acylates ... - PubMed
May 10, 1980 · Penicillin kills susceptible bacteria by specifically inhibiting the transpeptidase that catalyzes the final step in cell wall biosynthesis, the cross-linking ...
[87]
Rapid Determination of the Specificity Constant of Irreversible ...
Nov 16, 2015 · A simple approach to measuring kinact/KI was developed that makes use of an irreversible probe for competitive assays run to completion against test compounds.
[88]
[PDF] Enzyme Catalysis: inhibition
Sep 10, 2015 · Example of an irreversible inhibitor: Page 12. Inhibitor Types: Mechanism-based irreversible inhibitors. 10 September 2015. PHRM 836 - Devlin ...
[89]
Residual cyclooxygenase activity of aspirin-acetylated COX-2 forms ...
Aspirin inhibits the cyclooxygenase (COX) enzymes via a unique mechanism (1). Aspirin covalently modifies the enzyme by transfer of its acetyl group to Ser530 ...
[90]
Organophosphate Toxicity - StatPearls - NCBI Bookshelf - NIH
Nov 12, 2023 · These insecticides inactivate AChE by phosphorylating the serine hydroxyl group on the enzyme. As AChE is essential in acetylcholine degradation ...
[91]
An outlook on suicide enzyme inhibition and drug design - PMC
Oct 9, 2021 · Mechanism of suicide enzyme inhibition The precise mechanism of inactivation process will differ from one enzyme to another, but the catalytic ...
[92]
Mechanisms of action of FdUMP[10]: metabolite activation and ...
FdUMP[10] is a multimer of FdUMP, a suicide inhibitor of thymidylate synthase (TS), and was designed to bypass resistance to 5-fluorouracil (5FU).
[93]
From feedback inhibition to allostery: the enduring ... - FEBS Press
Aug 16, 2013 · ATCase is the first enzyme of the pyrimidine biosynthetic pathway, and is inhibited by CTP and UTP, the nucleotide end-products of the pathway.<|separator|>
[94]
None
### Summary of the Monod-Wyman-Changeux Model for Allosteric Transitions
[95]
Comparison of Experimental Binding Data and Theoretical Models ...
Comparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*. Click to copy article linkArticle link copied! D. E. Koshland, ...
[96]
Cooperative Binding - PMC - NIH
The Hill Equation This means that cooperativity is assumed to be fixed, i.e., it does not change with saturation. It also means that binding sites always ...
[97]
Protein posttranslational modifications in health and diseases
Phosphorylation is a reversible PTM, and the reverse process of phosphorylation is called dephosphorylation catalyzed by phosphatases (Figure 2A).
[98]
Glycogen Synthase - an overview | ScienceDirect Topics
Glycogen synthase exists in at least two forms: a phosphorylated form, arising from covalent modification of serine residues by ATP; and a dephosphorylated ...
[99]
Quantification of the glycogen cascade system: the ultrasensitive ...
Regulation of glycogen synthase and phosphorylase by reversible covalent modification cycles exemplifies signal transduction by enzyme cascades. Although ...
[100]
Mechanistic insights into the regulation of metabolic enzymes by ...
Examples are emerging where acetylation plays a similar role in directly regulating the amount of metabolic enzymes through targeting the substrate to ...
[101]
Biochemistry, Ubiquitination - StatPearls - NCBI Bookshelf - NIH
Ubiquitination is a 3-step process involving 3 enzymes: ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin-protein ligase (E3).
[102]
Zymogen Activation Confers Thermodynamic Stability on a Key ...
Trypsinogen is normally activated in the duodenum upon cleavage by enteropeptidase, but under pathological conditions can be susceptible to autoactivation in ...
[103]
Regulation of insulin secretion by the post-translational modifications
Aug 4, 2023 · Phosphorylation mediated signaling cascades play an important role in maintaining glucose homeostasis (Roder et al., 2016). The insulin ...
[104]
Physiology, Pepsin - StatPearls - NCBI Bookshelf - NIH
May 1, 2023 · A low pH (1.5 to 2) activates pepsin. Acetylcholine, gastrin, and histamine stimulate the proton pump in parietal cells to release hydrogen ions ...Introduction · Issues of Concern · Function · Pathophysiology
[105]
Effect of pH, temperature and media on acid and alkaline ... - NIH
The pH optimum for alkaline phosphatase activity was 9.0 for all of the isolates tested. The pH optimum for acid phosphatase activity was 5.8 for 67% of the ...
[106]
The combined effects of reactant kinetics and enzyme stability ... - NIH
Apr 23, 2017 · The Arrhenius equation was originally applied to describe the temperature dependence of chemical reaction rates in controlled settings, but it ...
[107]
Deoxyribonucleic acid polymerase from the extreme thermophile ...
A stable deoxyribonucleic acid (DNA) polymerase (EC 2.7.7.7) with a temperature optimum of 80 degrees C has been purified from the extreme thermophile Thermus
[108]
The Effect of Ionic Strength and Specific Anions on Substrate ... - NIH
With all salts there is an increase in the activity at low salt concentration (due to the activation by Na+) followed by a decline in rate of hydrolysis with ...
[109]
Interfacial Catalysis: The Mechanism of Phospholipase A2 - PMC - NIH
Calcium ion is essential both for the binding of substrate and for catalysis. Figure 4 shows the coordination geometry of the calcium-ion cofactor in the two ...<|separator|>
[110]
Thermal unfolding methods in drug discovery - PMC - PubMed Central
May 16, 2023 · The melting temperature (Tm) (dotted line) can be defined as the midpoint of the transition, or the temperature at which 50% of the protein ...
[111]
Thermally denatured state determines refolding in lipase - NIH
Upon denaturation of the parent at 75°C, possibly the protein unfolds into an intermediate that was prone to aggregation. At 95°C accumulation of the residual ...
[112]
Glycolysis: A multifaceted metabolic pathway and signaling hub - PMC
The pathway consists of 10 metabolic enzymes which work ... Enzymes of glycolysis are functionally associated with the mitochondrion in Arabidopsis cells.
[113]
Biochemistry, Glycolysis - StatPearls - NCBI Bookshelf - NIH
As described before, many enzymes are involved in the glycolytic pathway by converting one intermediate to another. Control of these enzymes, such as ...
[114]
Physiology, Krebs Cycle - StatPearls - NCBI Bookshelf
Nov 23, 2022 · Krebs Cycle). It comprises 8 enzymes within the mitochondrial ... number of enzymes produced in fasting and fed conditions. In the fed ...
[115]
Evolution and Functional Implications of the Tricarboxylic Acid Cycle ...
The tricarboxylic acid (TCA) cycle, a crucial component of respiratory metabolism, is composed of a set of eight enzymes present in the mitochondrial matrix.
[116]
A faster Rubisco with potential to increase photosynthesis in crops
Sep 17, 2014 · In photosynthetic organisms, d-ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is the major enzyme assimilating atmospheric CO2 ...Missing: enzyme | Show results with:enzyme
[117]
Structural basis for allosteric regulation of human ... - PubMed - NIH
Aug 25, 2024 · Phosphofructokinase-1 (PFK1) catalyzes the rate-limiting step of glycolysis, committing glucose to conversion into cellular energy.
[118]
Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of ...
Nov 24, 2021 · Both key glycolysis rate-limiting enzymes, hexokinase-II (HK-II), phosphofructokinase-1 (PFK-1), and pyruvate kinase M2 (PKM2), as well as indirect rate- ...
[119]
Compartmentalization and metabolic regulation of glycolysis - PMC
Glycolysis enzymes are typically diffuse, but under hypoxic stress, they form dynamic structures like G bodies, which are condensates, and may act as ...
[120]
Tracing Compartmentalized NADPH Metabolism in the Cytosol and ...
Apr 22, 2014 · Here we develop an approach to resolve NADP(H)-dependent pathways present within both the cytosol and the mitochondria. By tracing hydrogen in ...
[121]
Protein-protein interactions and metabolite channelling in the plant ...
May 16, 2017 · Protein complexes of sequential metabolic enzymes, often termed metabolons, may permit direct channelling of metabolites between the enzymes ...
[122]
The Roles of Molecular Chaperones in Regulating Cell Metabolism
While chaperones have been shown to directly impact the folding of a given client, they can also serve as mediators to regulate metabolic enzyme degradation ...
[123]
Signalling scaffolds and local organization of cellular behaviour - PMC
This Review examines the features of scaffold proteins and highlights examples of locally organized groups of signalling enzymes that drive essential ...
[124]
Phenylalanine Hydroxylase Deficiency - GeneReviews - NCBI - NIH
Mar 13, 2025 · Maternal phenylketonuria (MPKU) syndrome occurs in offspring of mothers with inadequately treated PAH deficiency during pregnancy and results ...Summary · Clinical Characteristics · Management · Genetic Counseling
[125]
Gaucher Disease - StatPearls - NCBI Bookshelf
Nov 12, 2023 · Gaucher disease results from mutations in the GBA1 gene, leading to deficient glucocerebrosidase activity within lysosomes.Continuing Education Activity · Etiology · Evaluation · Treatment / Management
[126]
Telomerase in Cancer: Function, Regulation, and Clinical Translation
Feb 5, 2022 · To do so, malignant cells reactivate telomerase to extend their telomeres and achieve cellular immortality, which is a “Hallmark of Cancer”.
[127]
Molecular biology of bcr-abl1–positive chronic myeloid leukemia
Decades of research zeroing in on the role of BCR-ABL1 kinase in the pathogenesis of CML have culminated in the development of highly efficacious therapeutics ...
[128]
Imatinib in Chronic Myeloid Leukemia: an Overview - PMC - NIH
Imatinib directly inhibits the constitutive tyrosine kinase activity. Imatinib binds to BCR-ABL kinase domain by preventing the transfer of a phosphate group to ...
[129]
Enzyme Replacement in Gaucher Disease - PMC - PubMed Central
What Does the Future Hold? The quality of life for patients with Gaucher disease has been greatly improved by the development of enzyme replacement therapy.
[130]
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
The principle of antibody-directed enzyme prodrug therapy is to use an antibody directed at a tumor-associated antigen to vector an enzyme to tumor sites. The ...
[131]
Myocardial Infarction Serum Markers - StatPearls - NCBI Bookshelf
CK-MB is released from skeletal muscle, and this can lead to falsely positive elevation. Per gram of myocardial tissue, more troponin is present than CK-MB.Introduction · Diagnostic Tests · Testing Procedures
[132]
The lost language of the RNA World | Science Signaling
Jun 13, 2017 · The possibility of an RNA World is based on the notion that life on Earth passed through a primitive phase without proteins.
[133]
The RNA World as a Model System to Study the Origin of Life
Oct 5, 2015 · We present a current view of the biochemistry of the origin of life, focusing on issues surrounding the emergence of an RNA World.<|separator|>
[134]
RNA, the first macromolecular catalyst: the ribosome is a ribozyme
The larger ribosomal subunit contains the site of peptide-bond formation – the peptidyl transferase centre. The ribosome has three. tRNA-binding sites: the A- ...
[135]
The nature of the last universal common ancestor and its impact on ...
Jul 12, 2024 · The last universal common ancestor (LUCA) is the node on the tree of life from which the fundamental prokaryotic domains (Archaea and Bacteria) diverge.
[136]
The very early evolution of biological complexity: Trends in Genetics
Sep 25, 2024 · The dating of the LUCA to around 4.2 billion years ago agrees with this broader timeline. However, this dating also gives only 100–200 million ...
[137]
ATP synthase evolution on a cross-braced dated tree of life - Nature
Nov 17, 2023 · The ATP synthase complex is thought to have originated prior to the Last Universal Common Ancestor (LUCA) and analyses of ATP synthase genes, ...
[138]
Functions predict horizontal gene transfer and the emergence of ...
Oct 22, 2021 · Interphylum HGT events are of particular importance as they likely contribute to the recent emergence of antibiotic resistance in pathogenic ...
[139]
Horizontal antimicrobial resistance transfer drives epidemics of ...
Apr 13, 2018 · Horizontal gene transfer has played a role in developing the global public health crisis of antimicrobial resistance (AMR).Results · Co-Circulating Msma... · Methods<|separator|>
[140]
Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective
We discuss the mechanistic enzymology of promiscuity--how enzymes, which generally exert exquisite specificity, catalyze other, and sometimes barely related, ...
[141]
The evolution of functional complexity within the β-amylase gene ...
Feb 28, 2019 · We identified eight distinct clades in angiosperms, which results from extensive gene duplications and sub- or neo-functionalization. We ...
[142]
Enzyme promiscuity: engine of evolutionary innovation - PubMed - NIH
Oct 31, 2014 · Catalytic promiscuity and substrate ambiguity are keys to evolvability, which in turn is pivotal to the successful acquisition of novel biological functions.
[143]
Nuclear moonlighting of cytosolic glyceraldehyde-3-phosphate ...
Jul 10, 2020 · Enzyme moonlighting is a phenomenon whereby an enzyme can perform secondary non-enzymatic functions acquired through evolution, such as ...
[144]
Directed Evolution of a Cytochrome P450 Carbene Transferase for ...
Jun 5, 2019 · We addressed this challenge by evolving a cytochrome P450 for highly efficient carbene transfer to indoles, pyrroles, and cyclic alkenes.
[145]
Review Industrial enzyme applications - ScienceDirect.com
Aug 1, 2002 · The majority of currently used industrial enzymes are hydrolytic in action, being used for the degradation of various natural substances.
[146]
Applications of Microbial Enzymes in Food Industry - PMC - NIH
The present review discusses the recent advancement in enzyme technology for food industries. A comprehensive list of enzymes used in food processing, the ...
[147]
https://pubmed.ncbi.nlm.nih.gov/20235827/
[148]
https://pubmed.ncbi.nlm.nih.gov/30819112/
[149]
https://pubmed.ncbi.nlm.nih.gov/25210039/
[150]
Enzyme Linked Immunosorbent Assay - StatPearls - NCBI Bookshelf
ELISA is a technique using enzymes to detect and quantify immunologic reactions, where a component is bound to a solid phase.
[151]
Horseradish peroxidase-triggered direct in situ fluorescent ...
Nov 21, 2021 · Usually, ELISA uses an enzyme, typically horseradish peroxidase (HRP) or alkaline phosphatase (ALP), to convert the corresponding substrate into ...
[152]
Enzymatic depolymerization of alginate by two novel thermostable ...
Sep 20, 2022 · Their application for degradation of alginate polymers produced by Pseudomonas aeruginosa in cystic fibrosis patients has been studied (Mrsny et ...Missing: therapy | Show results with:therapy
[153]
Thrombolytic Therapy - StatPearls - NCBI Bookshelf - NIH
Thrombolytic treatment, also known as fibrinolytic therapy, dissolves dangerous intravascular clots to prevent ischemic damage by improving blood flow.
[154]
Streptokinase for Treatment of Thrombotic Disorders: The End ... - NIH
PAs convert the endogenous human plasminogen (HPG: the inactive proenzyme) to plasmin (HPM: the active enzyme), which cleaves the fibrin network of the blood ...
[155]
CRISPR/Cas9 therapeutics: progress and prospects - Nature
Jan 16, 2023 · Promising applications for this technology include the treatment of cancers, cardiovascular diseases, sickle cell anemia, and neurodegenerative ...
[156]
Engineering cytochrome P450 enzyme systems for biomedical ... - NIH
Directed evolution has been widely applied to engineer P450s, the structures of which are often unknown, for desired properties under artificial selective ...
[157]
Streptokinase—a clinically useful thrombolytic agent - ScienceDirect
Native streptokinase is useful for cost-effective thrombolytic therapy in clinical practice, but its use is not risk free. Large quantities of streptokinase ...Research Review Paper · Thrombolysis Or Fibrinolysis · Streptokinase
[158]
PEGylated therapeutics in the clinic - PMC - PubMed Central
Sep 22, 2023 · Specifically, PEGylation can improve the parent drug's solubility, extend its circulation time, and reduce its immunogenicity, with minimal ...
[159]
Application of CRISPR-Cas9 genome editing technology in various ...
In biomedical research, CRISPR-Cas9 has facilitated the study of gene functions and disease mechanisms. It has enabled researchers to create targeted gene ...